Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Nucleus Genomics offers genetic testing services focused on fertility and health, covering Nucleus Health, Preview, Embryo, and IVF+. Based on the text, it is not a typical enterprise SaaS product, but rather a digital health platform combining “testing kits + Web App reports + genetic counseling + clinic collaboration.” Its main goal is to help users understand genetic risks before pregnancy, during IVF, and at the embryo selection stage.
Preview is designed for individuals or couples preparing for pregnancy. It uses a cheek swab for whole-genome testing, with reports covering 2,000+ conditions and traits, including rare genetic diseases, cancer, heart disease, diabetes, Alzheimer’s disease, as well as probabilistic traits such as height, eye color, and IQ. Embryo is intended for IVF scenarios: parents first complete Preview, then up to 20 embryos are analyzed, with genetic optimization software covering 30+ disease- and trait-related factors. IVF+ goes a step further by offering clinic matching, one IVF cycle, medications, STD/AMH testing, ICSI, and counseling during treatment. Results are delivered through a Nucleus account and Web App, with downloadable reports that can be shared with doctors, as well as access to support from genetic counselors.
The text clearly lists Embryo at $9,999. IVF+ starts at $9,999 per month for four months, depending on clinic location. The specific prices for Health and Preview appear as placeholders in the collected content and could not be confirmed. Each kit includes the first year of membership; after that, it renews annually per person/kit and can be canceled at any time. Free shipping and return shipping are available in the U.S., and the service is marked as HSA/FSA eligible.
The main strength is its complete service chain, with a clear connection from preconception testing to embryo analysis and IVF services. It claims over 99.9% accuracy for whole-genome DNA analysis. Embryo can integrate with existing IVF clinics and is said to be trusted by 165+ clinics. The drawbacks are that results for common diseases and complex traits are inherently probabilistic predictions, not diagnoses; pricing information is not fully transparent; and the product involves highly sensitive genetic and reproductive decisions that require professional interpretation and ethical judgment.
It is suitable for families planning to have children, those concerned about a family history of genetic disease, people undergoing IVF, or those who want more comprehensive embryo information. It may also suit IVF clinic partnership scenarios. International shipping lists countries such as the United States, Canada, the United Kingdom, Germany, and India, but does not list mainland China. Access from China is not disclosed in the text, so it is considered unknown.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on mynucleus.com official site.
mynucleus.com is an United States Health provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach mynucleus.com directly.